TRANSCEND CAPITAL ADVISORS, LLC Pfizer Inc. Transaction History

TRANSCEND CAPITAL ADVISORS, LLC portfolio value:

$3.31M
portfolio value

TRANSCEND CAPITAL ADVISORS, LLC quarter portfolio value change:

-16.54%
quarter

Pfizer Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.39% -1.06K shares -712K $43.76 75.67K
Q2 2022 share Increase +0.64% 490 shares 76K $52.43 76.74K
Q1 2022 share Increase +8.64% 6.06K shares -197K $51.77 76.25K
Q4 2021 share Increase +2.99% 2.03K shares 1.17M $58.4 70.19K
Q3 2021 share Increase +0.93% 628 shares 324K $42.63 68.15K
Q2 2021 share Increase +6.38% 4.04K shares 348K $38.46 67.52K
Q1 2021 share Increase +1.19% 748 shares -12K $35.24 63.47K
Q4 2020 share Decrease -45.24% -51.82K shares -1.68M $35.41 62.73K
Q3 2020 share Increase +32.00% 27.77K shares 1.29M $33.15 114.55K
Q2 2020 share Decrease -8.08% -7.63K shares -237K $29.25 86.78K
Q1 2020 share Increase +0.83% 780 shares -551K $28.9 94.42K
Q4 2019 share Increase 0.00% 93.64K shares 3.48M $34.34 93.64K